217 related articles for article (PubMed ID: 25784665)
1. Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1.
Plummer MP; Jones KL; Cousins CE; Trahair LG; Meier JJ; Chapman MJ; Horowitz M; Deane AM
Diabetes Care; 2015 Jun; 38(6):1123-9. PubMed ID: 25784665
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects.
Plummer MP; Jones KL; Annink CE; Cousins CE; Meier JJ; Chapman MJ; Horowitz M; Deane AM
Diabetes Care; 2014 Jun; 37(6):1509-15. PubMed ID: 24598243
[TBL] [Abstract][Full Text] [Related]
3. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Deane AM; Nguyen NQ; Stevens JE; Fraser RJ; Holloway RH; Besanko LK; Burgstad C; Jones KL; Chapman MJ; Rayner CK; Horowitz M
J Clin Endocrinol Metab; 2010 Jan; 95(1):215-21. PubMed ID: 19892837
[TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
[TBL] [Abstract][Full Text] [Related]
5. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.
Umapathysivam MM; Lee MY; Jones KL; Annink CE; Cousins CE; Trahair LG; Rayner CK; Chapman MJ; Nauck MA; Horowitz M; Deane AM
Diabetes; 2014 Feb; 63(2):785-90. PubMed ID: 24089511
[TBL] [Abstract][Full Text] [Related]
8. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.
Deane AM; Chapman MJ; Fraser RJ; Burgstad CM; Besanko LK; Horowitz M
Crit Care; 2009; 13(3):R67. PubMed ID: 19439067
[TBL] [Abstract][Full Text] [Related]
9. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Salehi M; Vahl TP; D'Alessio DA
J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
[TBL] [Abstract][Full Text] [Related]
10. Exogenous glucagon-like peptide-1 attenuates glucose absorption and reduces blood glucose concentration after small intestinal glucose delivery in critical illness.
Miller A; Deane AM; Plummer MP; Cousins CE; Chapple LS; Horowitz M; Chapman MJ
Crit Care Resusc; 2017 Mar; 19(1):37-42. PubMed ID: 28215130
[TBL] [Abstract][Full Text] [Related]
11. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
Rayner CK; Watson LE; Phillips LK; Lange K; Bound MJ; Grivell J; Wu T; Jones KL; Horowitz M; Ferrannini E; Tricò D; Frascerra S; Mari A; Natali A
Diabetes Care; 2020 Aug; 43(8):1813-1821. PubMed ID: 32471908
[TBL] [Abstract][Full Text] [Related]
12. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
13. Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type-I diabetic patients.
Petrakis IE; Chalkiadakis G; Vrachassotakis N; Sciacca V; Vassilakis SJ; Xynos E
Dig Dis; 1999; 17(4):241-7. PubMed ID: 10754365
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects.
Petrakis IE; Kogerakis N; Vrachassotakis N; Stiakakis I; Zacharioudakis G; Chalkiadakis G
Abdom Imaging; 2002; 27(3):309-14. PubMed ID: 12173362
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
Vollmer K; Gardiwal H; Menge BA; Goetze O; Deacon CF; Schmidt WE; Holst JJ; Meier JJ
J Clin Endocrinol Metab; 2009 Apr; 94(4):1379-85. PubMed ID: 19174495
[TBL] [Abstract][Full Text] [Related]
16. The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
Brønden A; Albér A; Rohde U; Gasbjerg LS; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2018 Feb; 20(2):362-369. PubMed ID: 28786523
[TBL] [Abstract][Full Text] [Related]
17. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
[TBL] [Abstract][Full Text] [Related]
18. Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men.
Bitarafan V; Fitzgerald PCE; Little TJ; Meyerhof W; Jones KL; Wu T; Horowitz M; Feinle-Bisset C
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R263-R273. PubMed ID: 31774306
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
[TBL] [Abstract][Full Text] [Related]
20. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
